Latest filing published 26 Sept 2023 for Reata Pharmaceuticals INC. Read the official filing
No signal scores available.
This profile gathers the share dealings of William Rose in Reata Pharmaceuticals Inc. Over a trading history stretching from 23 August 2023 to 26 September 2023, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 26 September 2023 with a transaction in Reata Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations